Early beta-blocker exposure and association with brain injury biomarkers following moderate to severe traumatic brain injury: A TRACK-TBI study

There was no association between early beta-blocker exposure and the primary outcome which was blood-based brain injury biomarker levels on day 3. In exploratory analysis, we found that early beta-blocker may associated with decreased NSE level on day 14. Due to the retrospective nature of the study and the use of propensity-weighted analysis to identify associations, direct clinical practice changes cannot be recommended. However, the significant association with NSE level warrants further investigation through prospective studies or randomized controlled trials to confirm the potential neuroprotective effect of early beta-blocker exposure on neuronal cellular injury.

Authors

Institutions

Publication Details

Journal
Journal of the Intensive Care Society
Published
2025-06-29
DOI
https://doi.org/10.1177/17511437251349680
Primary Topic
S100 Proteins and Annexins
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early beta-blocker exposure and association with brain injury biomarkers following moderate to severe traumatic brain injury: A TRACK-TBI study

Jason Barber, Joseph P. Mathew, Adrian F. Hernandez, Jordan Hatfield et al.
Journal of the Intensive Care Society
S100 Proteins and Annexins
article

Early beta-blocker exposure and association with brain injury biomarkers following moderate to severe traumatic brain injury: A TRACK-TBI study

Jason Barber, Joseph P. Mathew, Adrian F. Hernandez, Jordan Hatfield, Miriam M. Treggiari, Jordan Komisarow, Ramesh Grandhi, Michael L. James, Joseph Miller, Tetsu Ohnuma, Nancy Temkin, Vijay Krishnamoorthy, Geoffrey A. Manley, Pattrapun Wongsripuemtet, Daniel T. Laskowitz, Karthik Raghunathan, Nophanan Chaikittisilpa, Cina Sasannejad, Ben Goldstein, Monica S. Vavilala, Katharine Colton
article en

Abstract

There was no association between early beta-blocker exposure and the primary outcome which was blood-based brain injury biomarker levels on day 3. In exploratory analysis, we found that early beta-blocker may associated with decreased NSE level on day 14. Due to the retrospective nature of the study and the use of propensity-weighted analysis to identify associations, direct clinical practice changes cannot be recommended. However, the significant association with NSE level warrants further investigation through prospective studies or randomized controlled trials to confirm the potential neuroprotective effect of early beta-blocker exposure on neuronal cellular injury.

Journal of the Intensive Care SocietyVol. 26(4)
Siriraj Hospital (TH), Henry Ford Health System (US), Duke University (US), University of California, San Francisco (US), University of Washington (US), University of Utah (US), Mahidol University (TH), Neurological Surgery (US)
National Institutes of Health
Good health and well-being
Openalex Percentile: Top 86%
S100 Proteins and Annexins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.